手性流动相添加剂法拆分比索洛尔对映体

以羧甲基-β-环糊精作为手性流动相添加剂,建立了高效液相色谱拆分比索洛尔对映体的方法。系统考察了手性添加剂的种类及浓度、流动相中甲醇的含量、pH值和流速等因素对拆分的影响。色谱分离条件:流动相甲醇∶乙腈∶水为20∶67∶13(V/V/V),羧甲基-β-环糊精浓度为0.5g.L-1,pH值为4.07(以三乙胺-冰乙酸调节),流速为0.3mL.min-1,检测波长223nm,对映体得到基线分离,分离度为1.89。     

直链淀粉手性固定相高效液相色谱法拆分比索洛尔对映体

采用直链淀粉手性固定相高效液相色谱法在正相条件下直接拆分了比索洛尔对映异构体。分别以异丙醇、乙醇为有机改性剂,考察了流动相的组成与配比、流速及柱温等因素对比索洛尔对映体分离的影响。确定了比索洛尔对映体的最佳拆分条件:流动相正己烷-乙醇-二乙胺(体积比为88∶12∶0.1),流速0.6 mL/min,检测波长270 nm,柱温20 ℃。该方法可快捷、简便地拆分比索洛尔对映体。     

Liquid chromatography tandem mass spectrometry method for determination of bisoprolol in human plasma using d5‐bisoprolol as the internal standard

A simple, reliable and sensitive liquid chromatography tandem mass spectrometry (LC‐MS/MS) protocol was developed and validated for quantification of bisoprolol in human plasma. The sample was pretreated with a simple procedure of protein precipitation and an isotope‐labeled d5‐bisoprolol was used as internal standard. The chromatographic separation was performed on a Capcell Pak C₁₈ MG III column (100 mm × 2.0 mm, 5 µm). The protonated ion of the analyte was detected in positive ionization by multiple reaction monitoring mode. The mass transition pairs of m/z 326.3 → 116.3 and m/z 331.3 → 121.3 were used to detect bisoprolol and the internal standard, respectively. Linearity, accuracy, precision, recovery, matrix effect, dilution test and stability were evaluated during method validation over the range of 0.5–100 ng/mL. The validated method was successfully applied to analyze human plasma samples in a bisoprolol bioavailability study. Copyright © 2009 John Wiley & Sons, Ltd.     

A Novel Molecularly Imprinted Potentiometric Sensor for the Fast Determination of Bisoprolol Fumarate in Biological Samples

In this study, molecularly imprinted polymer (MIP) was prepared and used in the preparation of carbon paste electrode (CPE) for the quantification of bisoprolol fumarate (BF) in pure, pharmaceutical formulation and biological fluids. The selective MIP for BF was synthesized from methacrylic acid as the functional monomer, ethylene glycol dimethacrylate as the cross-linker in dimethyl sulfoxide solution, BF as the template molecule and 2, 2-azobisisobutyronitrile (AIBN) as the initiator. The non-imprinted polymer (NIP) was synthesized by the same procedure, but in the absence of the template molecule then incorporated in the paste of the carbon paste electrodes (CPEs). The prepared MIP for BF and its corresponding NIP were well characterized using scanning electron microscopy (SEM), Fourier transform infrared spectrometer, and thermal gravimetric analysis (TGA). The MIP and NIP based CPEs were further used for the determination of BF and the obtained results indicated that the sensor modified by the MIP have much higher recognition power for the BF molecules than the NIP based sensor where the MIP based CPE exhibited a Nernstian response 29.50±0.55 mV decade⁻¹ within a concentration range of 1.0×10⁻⁷–1.0×10⁻² mol L⁻¹and pH independence in the range 3.50–7.15. The proposed sensor has high selectivity over several possible interfering compounds. The obtained results by the proposed sensor were satisfactory with excellent percentage recovery and relative standard deviation and were comparable with those obtained from HPLC reported method.     

手性毛细管电色谱拆分比索洛尔、阿替洛尔、克仑特罗和特布他林

以万古霉素(vancomycin)毛细管柱为手性分离色谱柱,采用CLC和pCEC方法,对比索洛尔、阿替洛尔、克仑特罗和特布他林进行了手性拆分研究。在CLC方法中,上述4种物质均在甲醇/异丙醇/三乙胺/冰醋酸(60/40/0.05/0.1,V/V)条件下获得最大分离,分离度(Rs)分别为1.9、1.4、1.1和0.9。在pCEC方法中,采用极性有机模式时,Rs分别为1.9、1.4、1.5和1.5;采用反相模式时,Rs分别为2.0、1.7和1.2,而特布他林则未获分离。该方法能有效拆分比索洛尔、阿替洛尔、克仑特罗和特布他林,而且CLC、pCEC极性有机模式和pCEC反相模式之间有着较强的互补关系。     

毛细管电泳-激光诱导荧光法测定人血浆中的富马酸比索洛尔

建立了毛细管电泳-激光诱导荧光检测(CE-LIFD)技术测定人血浆中富马酸比索洛尔含量的新方法。选用荧光素异硫氰酸酯(FITC)为衍生化试剂,当缓冲溶液为25mmol/LNa2B4O7(pH9.2)、分离电压25kV、柱温20℃、电动进样(10kV×8s)、以峰面积内标法定量、于激发波长/发射波长=488/520nm柱上检测时,富马酸比索洛尔得到较好分离。在选定的电泳条件下,对其线性范围(20～1000μg/L)、检出限(10μg/L)、重现性(日内和日间精密度分别小于4.44%和5.59%)和回收率(96.19%～101.80%)进行了测定。结果表明:迁移时间的重现性<1.58%;峰面积之比的重现性<6%。     

Liquid chromatographic-electrospray tandem mass spectrometric determination of bisoprolol in human plasma

An analytical method for the determination of bisoprolol in human plasma has been developed based on liquid chromatography-tandem mass spectrometry (LC-MS/MS). The analyte and internal standard (IS) diphenhydramine were cleaned up by protein precipitation with acetonitrile, reconstituted in mobile phase and separated by reversed-phase high-performance liquid chromatography (HPLC) using methanol:10 mm ammonium acetate:formic acid (70:30:0.1 v/v/v) as mobile phase. Detection was carried out by multiple reaction monitoring (MRM) on an LC-MS/MS system and was completed within 2.5 min. The assay was linear over the range 0.5-100 ng/mL with a limit of quantitation (LOQ) of 0.5 ng/mL. The intra- and inter-day precision levels were within 5.54 and 9.95%, respectively, while the accuracy was in the range 89.4-113%. This method has been utilized in a pharmacokinetic study, where healthy volunteers were treated with an oral dose of 5 mg bisoprolol.